-
Add a new resource on menopause management to your clinical practice. The North American Menopause Society (NAMS) has just updated its guidelines on postmenopausal hormone therapy.
-
Regulatory review of a second human papillomavirus (HPV) vaccine has been delayed. GlaxoSmithKline has announced plans to submit additional data from its large-scale clinical trial for its vaccine candidate, Cervarix.
-
If your clinic is using oral fluid samples for rapid HIV testing, be sure to monitor for false-positive results.
-
Extending the current grace period for reinjection of the contraceptive shot depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer) from two to four weeks does not increase pregnancy risk and could increase contraceptive continuation, indicate findings from a newly published study.
-
-
A class for caregivers was established at the University of Minnesota, Fairview in Minneapolis, because caring for an ill family member is becoming common practice as more people are treated as outpatients.
-
When behavioral health patients who have been hospitalized receive interventions in their home, their compliance with treatment recommendations increases and hospital readmission drops, a study by PsycHealth Ltd.'s Home Intervention Program has found.
-
The collaboration between a commercial health plan and a physician group practice will be able to promote optimal care for patients because the partners have a different focus and outlook, says Barbara Walters, DO, senior medical director for Dartmouth-Hitchcock.
-
In an example other employers may want to strongly consider, hospitals around the country are re-creating their cafeterias as they strive to become healthier places to work.
-
End-of-life issues should be discussed while people are in good health. Just as people prepare for birth, it is important to prepare for death.